Latest Schedule 13G passive stakes

Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have filed a Schedule 13G detailing their beneficial ownership of Iveda Solutions, Inc. common stock, limited by warrant conversion restrictions.

Van Eck Associates Corporation has filed a Schedule 13G, reporting beneficial ownership of 9.7% of Denison Mines Corp. common stock.

Commodore Capital LP and its affiliates have reported a beneficial ownership of 1.8% of Definium Therapeutics, Inc. common shares, acquiring them through a combination of direct holdings and pre-funded warrants.

Vivo Opportunity Fund Holdings, L.P. and its affiliates have disclosed beneficial ownership of 9.99% of SAB Biotherapeutics, Inc. common stock, including convertible securities and warrants.

Lynwood Capital Management Inc., Ben Shapiro, and Lynwood Opportunities Master Fund have reported beneficial ownership of 5.0% of Rein Therapeutics, Inc. common stock as of June 30, 2026.

Van Eck Associates Corporation has reported a beneficial ownership of 6.5% in Coeur Mining, Inc., holding 67,029,794 shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Breeze Acquisition Corp II's ordinary shares as of June 30, 2026.

Point72 Asset Management, L.P. and related entities have reported beneficial ownership of 3.8% of Design Therapeutics, Inc. common stock as of June 30, 2026.

Jericho Capital Asset Management L.P. and Josh Resnick have reported beneficial ownership of 7.2% of Core Scientific, Inc.'s common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Breeze Acquisition Corp II's ordinary shares as of June 30, 2026.

Vestal Point Capital, LP, through its managed funds, has disclosed beneficial ownership of 8,050,000 shares, representing 7.8% of Nurix Therapeutics, Inc. common stock.

Lynrock Lake LP, Lynrock Lake Partners LLC, and Cynthia Paul have collectively disclosed a beneficial ownership of 12.1% in TechTarget, Inc., holding 8,751,835 shares.

A filing reveals that Japan Post Holdings and J&A Alliance entities now collectively hold a 10.15% stake in Aflac Inc., with the reporting date of August 12, 2026.

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, reporting beneficial ownership of 7,227,778 shares, representing 6.96% of Nurix Therapeutics' common stock as of June 30, 2026.

Karpus Management, Inc. has updated its Schedule 13G filing to reflect its beneficial ownership of 7.05% of DWS Municipal Income Trust's common stock as of June 30, 2026.

D. E. Shaw & Co., L.P. and related entities have filed an amendment to their Schedule 13G, reporting 0% beneficial ownership of Range Capital Acquisition Corp. ordinary shares.

Point72 Asset Management, L.P., along with affiliated entities and Steven A. Cohen, has reported beneficial ownership of 6.6% of AIB Data Centers Inc. common stock as of June 30, 2026.

Citadel entities have amended their Schedule 13G filing, reporting a combined beneficial ownership of 5.8% in Greenland Energy Company as of June 30, 2026.

Park West Asset Management LLC, Park West Investors Master Fund, Limited, and Peter S. Park have jointly filed a Schedule 13G, reporting a significant beneficial ownership in Glass House Brands Inc.

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, reporting beneficial ownership of 3,900,000 shares, representing 6.78% of Enovis Corporation's common stock.

Citadel entities have reported an amendment to their Schedule 13G filing, indicating a shift in beneficial ownership of FG Nexus Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have amended their Schedule 13G filing regarding their beneficial ownership of American Exceptionalism Acquis Class A ordinary shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have amended their Schedule 13G filing regarding their beneficial ownership of American Exceptionalism Acquis Class A ordinary shares.

Karpus Management, Inc. has filed an amended Schedule 13G, confirming beneficial ownership of 529,003 shares, representing 8.83% of Western Asset Investment Grade Opportunity Trust Inc.

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, reporting beneficial ownership of 5,981,953 shares of Mission Produce, Inc. common stock, representing 6.77% of the outstanding shares.

Citadel entities have updated their beneficial ownership of Draganfly Inc. common shares, reporting a combined stake of up to 1.0%.

Citadel entities have updated their beneficial ownership filings for Boundless Bio, Inc., reporting a combined 0.6% stake.

Baker Bros. Advisors LP and affiliated entities have disclosed beneficial ownership of 11,443,357 shares, representing 5.3% of Revolution Medicines, Inc.'s outstanding common stock as of June 30, 2026.

Robert Randolph Neugebauer has filed an amendment to Schedule 13G, reporting beneficial ownership of less than 5% of Fermi Inc.'s common stock as of June 30, 2026.

Canada Pension Plan Investment Board reports a 3.3% beneficial ownership of Equitable Holdings, Inc. common stock as of June 30, 2026.